Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zihua Wenfei Zhike granules is a traditional Chinese medicine (TCM) formulation developed by the Guangdong Provincial Hospital of Traditional Chinese Medicine. It is specifically indicated for the treatment of postinfectious cough (PIC) presenting with the 'wind-cold fettering the lung' pattern. The granules are composed of multiple herbal extracts intended to warm the lung, disperse cold, and suppress cough. The drug has been evaluated in Phase II clinical trials (e.g., CTR20222656) to determine its efficacy and safety compared to placebo in patients with persistent cough following respiratory tract infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zihua Wenfei Zhike granules.